Su C - Search Results

1

Treatment of inflammatory bowel disease with azathioprine and 6-mercaptopurine.

Su C, Lichtenstein GR. Su C, et al. Gastroenterol Clin North Am. 2004 Jun;33(2):209-34, viii. doi: 10.1016/j.gtc.2004.02.004. Gastroenterol Clin North Am. 2004. PMID: 15177535 Review.

2

A novel therapy for colitis utilizing PPAR-gamma ligands to inhibit the epithelial inflammatory response.

Su CG, Wen X, Bailey ST, Jiang W, Rangwala SM, Keilbaugh SA, Flanigan A, Murthy S, Lazar MA, Wu GD. Su CG, et al. J Clin Invest. 1999 Aug;104(4):383-9. doi: 10.1172/JCI7145. J Clin Invest. 1999. PMID: 10449430 Free PMC article.

3

Azathioprine or 6-mercaptopurine for inflammatory bowel disease: do risks outweigh benefits?

Su CG, Stein RB, Lewis JD, Lichtenstein GR. Su CG, et al. Dig Liver Dis. 2000 Aug-Sep;32(6):518-31. doi: 10.1016/s1590-8658(00)80010-9. Dig Liver Dis. 2000. PMID: 11057928 Review.

4

An open-label trial of the PPAR-gamma ligand rosiglitazone for active ulcerative colitis.

Lewis JD, Lichtenstein GR, Stein RB, Deren JJ, Judge TA, Fogt F, Furth EE, Demissie EJ, Hurd LB, Su CG, Keilbaugh SA, Lazar MA, Wu GD. Lewis JD, et al. Among authors: su cg. Am J Gastroenterol. 2001 Dec;96(12):3323-8. doi: 10.1111/j.1572-0241.2001.05333.x. Am J Gastroenterol. 2001. PMID: 11774944

5

Extraintestinal manifestations of inflammatory bowel disease.

Su CG, Judge TA, Lichtenstein GR. Su CG, et al. Gastroenterol Clin North Am. 2002 Mar;31(1):307-27. doi: 10.1016/s0889-8553(01)00019-x. Gastroenterol Clin North Am. 2002. PMID: 12122740 Review.

6

Efficacy of anti-tumor necrosis factor therapy in patients with ulcerative colitis.

Su C, Salzberg BA, Lewis JD, Deren JJ, Kornbluth A, Katzka DA, Stein RB, Adler DR, Lichtenstein GR. Su C, et al. Am J Gastroenterol. 2002 Oct;97(10):2577-84. doi: 10.1111/j.1572-0241.2002.06026.x. Am J Gastroenterol. 2002. PMID: 12385442

7

Recent developments in inflammatory bowel disease.

Su C, Lichtenstein GR. Su C, et al. Med Clin North Am. 2002 Nov;86(6):1497-523. doi: 10.1016/s0025-7125(02)00085-8. Med Clin North Am. 2002. PMID: 12510462 Review.

8

The role of biological therapy in inflammatory bowel disease.

Su CG, Judge TA, Lichtenstein GR. Su CG, et al. Drugs Today (Barc). 2001 Feb;37(2):121-133. doi: 10.1358/dot.2001.37.2.614848. Drugs Today (Barc). 2001. PMID: 12783103

9

O brother, where art thou? The case for siblings, environment, and inflammatory bowel disease.

Su C. Su C. Inflamm Bowel Dis. 2003 May;9(3):211-2. doi: 10.1097/00054725-200305000-00013. Inflamm Bowel Dis. 2003. PMID: 12797350 No abstract available.

10

A meta-analysis of the placebo rates of remission and response in clinical trials of active Crohn's disease.

Su C, Lichtenstein GR, Krok K, Brensinger CM, Lewis JD. Su C, et al. Gastroenterology. 2004 May;126(5):1257-69. doi: 10.1053/j.gastro.2004.01.024. Gastroenterology. 2004. PMID: 15131785 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results